PX1 Research supplies analytical-grade Vilon (Lys-Glu) manufactured under stringent laboratory protocols for preclinical research. Dedicated to scientific integrity, our reagents undergo rigorous lot-specific analytical verification to support reproducible cell culture and biomolecular assays.
PX1 Research supplies analytical-grade Vilon (Lys-Glu) manufactured under stringent laboratory protocols for preclinical research. Dedicated to scientific integrity, our reagents undergo rigorous lot-specific analytical verification to support reproducible cell culture and biomolecular assays.
Principal investigators seeking to buy Vilon cell regeneration peptide for laboratory research must source analytical-grade compounds with verified purity. Vilon (Lysyl-Glutamic acid) is a synthetic short bioregulatory dipeptide investigated in preclinical models for its ability to modulate chromatin structure, activate specific gene expression patterns, and support cellular renewal mechanisms.
When purchasing reagents for sensitive cell culture or tissue engineering assays, selecting high-grade material is vital. PX1 Research provides reference-standard research peptides manufactured in GMP-compliant, ISO 17025 accredited facilities within the United States. Every lot is distributed exclusively for in vitro and laboratory research use only.
Vilon is a ultra-short bioregulatory peptide consisting of two L-amino acid residues: L-lysine and L-glutamic acid (H-Lys-Glu-OH). With a molecular weight of approximately 275.3 g/mol, its minimal sequence length allows for efficient interaction with nucleosomal structures and target nuclear receptors in experimental assays.
As a synthetic analog derived from thymic peptide research, Vilon belongs to a class of short peptide regulators that bypass standard protein degradation cascades to directly influence nuclear machinery. Laboratories evaluating chromatin condensation, DNA-protein interactions, and histone binding utilize high-purity research peptides to establish baseline kinetic models.
In vitro data indicate that short regulatory dipeptides like Vilon penetrate target cell membranes and localize within the cell nucleus. Preclinical studies suggest that the basic lysine residue combined with the acidic glutamic acid residue enables specific binding interactions with the major and minor grooves of double-stranded DNA.
Through these interactions, Vilon has been observed in laboratory models to promote decondensed heterochromatin structures. By inducing local chromatin unwinding, the dipeptide facilitates transcription factor accessibility to previously silenced gene promoters, particularly those responsible for structural protein synthesis, cell cycle regulation, and stress response mechanisms.
Preclinical investigation into cellular senescence has demonstrated that short peptide bioregulators exert distinct protective effects against age-associated cellular degradation. In cultured human fibroblast models, exposure to Vilon was observed to maintain proliferative capacity across extended passage counts, delaying the onset of phenotypic senescence markers.
Furthermore, animal studies investigating surgical and thermal wound models indicate that Vilon administration accelerates local tissue repair cascades. Laboratory observations show elevated levels of extracellular matrix protein synthesis, enhanced fibroblast migration, and increased transcription of endogenous growth factor genes in treated cohorts relative to controls.
Understanding the specific operational profile of Vilon requires comparing it against other well-characterized bioregulatory peptides evaluated in life sciences research. While Vilon (Lys-Glu) focuses primarily on thymic microenvironment signaling, chromatin decondensation, and connective tissue renewal pathways, related short peptides target distinct physiological systems.
For instance, investigators comparing immunomodulatory and epigenetic regulators often evaluate Epitalon, a synthetic tetrapeptide studied for telomerase activation and pineal gland regulation; Thymogen, a dipeptide (Glu-Trp) focused heavily on T-lymphocyte differentiation and adaptive immune response assays; and Pinealon, a tripeptide (Glu-Asp-Arg) evaluated primarily in neuronal cell culture models for neuroprotective effects. To explore detailed mechanistic breakdowns of short peptide gene activation, reference our comprehensive Epitalon gene expression research synthesis.
Beyond its direct cellular regeneration properties, Vilon has been studied for its role in modulating immune cell populations. Preclinical data show that Lys-Glu dipeptides act upon thymic epithelial cultures to promote the maturation of early T-cell lineages and influence cytokine expression profiles.
In vitro splenocyte assays demonstrate that Vilon exposure modulates the balance of pro-inflammatory and anti-inflammatory cytokines, including interleukin-2 (IL-2) and interferon-gamma (IFN-γ). Researchers utilize these findings to model immune system reactivation in models of chronic inflammation, environmental toxicity, and age-related immunosenescence.
For cell culture and biochemical research, compound purity directly correlates with experimental reproducibility. Impurities such as truncated peptide fragments, residual TFA (trifluoroacetic acid), or bacterial endotoxins can confound experimental outcomes and introduce unintended cytotoxic variables.
PX1 Research ensures that every batch of Vilon undergoes rigorous analytical verification: reverse-phase high-performance liquid chromatography (RP-HPLC) to guarantee sequence purity ≥98%, electrospray ionization mass spectrometry (ESI-MS) to verify exact molecular identity, and Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below strictly controlled thresholds (<0.01 EU/mg). Comprehensive documentation is provided via a third-party Certificate of Analysis (COA) for every lot.
Lyophilized Vilon dipeptide powder exhibits high solubility in aqueous buffer systems due to its polar amino acid side chains. For optimal stability and minimal degradation during in vitro testing, researchers should adhere to standardized reconstitution protocols.
Reconstitution should be conducted using sterile laboratory-grade solvents, such as Bacteriostatic Water (0.9% benzyl alcohol) or sterile Phosphate-Buffered Saline (PBS, pH 7.4). Avoid high-shear mechanical agitation or aggressive vortexing; gentle swirling ensures complete dissolution without inducing peptide shear. For exact liquid calculations and dilution protocols, refer to our peptide reconstitution calculator guide.
To preserve structural integrity over extended experimental timelines, lyophilized Vilon should be stored at -20°C in a desiccated environment protected from light exposure. Under these sealed conditions, the dry peptide compound maintains stability for up to 24 months.
Once reconstituted into solution, aliquots should be prepared to prevent repeated freeze-thaw cycles, which can cause hydrolysis and degradation of the peptide bond. Liquid solutions should be kept at 4°C for short-term assays (under 7 days) or sub-zero (-80°C) for long-term storage. Detailed environmental handling instructions are accessible via our lyophilized peptide storage protocols reference hub.
PX1 Research operates as a trusted USA-based supplier for academic, corporate, and private research laboratories worldwide. Orders are processed with same-day dispatch from our centralized logistics centers in California and Arizona to maintain strict chain-of-custody controls.
Institutions requiring high-volume orders, bulk quantities, or custom synthesis parameters can establish a dedicated account through our wholesale portal. Researchers looking to secure analytical-grade reagents can inspect current batch availability on the official Vilon product page or review broader analytical literature within the centralized PX1 Research hub.
What is Vilon used for in laboratory research?
Vilon (Lys-Glu) is utilized in preclinical research to study chromatin decondensation, epigenetic gene activation, cellular senescence in fibroblast cultures, immune cell maturation pathways, and tissue regeneration mechanisms.
How is the purity of PX1 Research Vilon verified?
Every lot of Vilon undergoes analytical testing at an independent ISO 17025 accredited facility. Verification includes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity (≥98%), Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight verification, and LAL testing for endotoxins.
What solvent is recommended for reconstituting Vilon for in vitro assays?
Vilon is highly soluble in aqueous media. Sterile Phosphate-Buffered Saline (PBS, pH 7.4), Sterile Water for Injection, or Bacteriostatic Water are standard solvents used for laboratory reconstitution.
Is Vilon approved for human clinical use or consumption?
No. Vilon supplied by PX1 Research is strictly sold as a research chemical compound for laboratory, in vitro, and preclinical research applications only. It is not for human or veterinary use, therapy, or consumption.
How does Vilon differ structurally from Thymogen?
While both are thymic-derived bioregulatory dipeptides, Vilon consists of Lysine and Glutamic Acid (Lys-Glu), whereas Thymogen consists of Glutamic Acid and Tryptophan (Glu-Trp). Consequently, they engage different gene expression profiles and receptor targets.
What are the storage guidelines for reconstituted Vilon solutions?
Reconstituted Vilon solutions should be aliquoted to avoid freeze-thaw cycles. Short-term storage (up to 7 days) is acceptable at 4°C, while long-term stability requires storage at -80°C.
What endotoxin limits are maintained for PX1 Research peptides?
PX1 Research enforces stringent endotoxin limits, ensuring levels remain below <0.01 EU/mg to prevent endotoxin-induced background noise in cell culture and immunological assays.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in US-based GMP-compliant facilities and shipped directly from fulfillment centers located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.